JAZZ Jazz Pharmaceuticals plc - Ordinary Shares
$254,94
Fiyat · Ağu 19, 2026
Temel veriler itibarıyla Ağu 3, 2026
52 Haftlık Aralık
$118–$265
93% of range
Analist Derecelendirmesi
BUY
26 analysts
Fiyat Hedefi
$281
+10% upside
P/E (TTM)
-29.1
ROE
—
Net Kâr Marjı
—
Jazz Pharmaceuticals plc - Ordinary Shares Hakkında Wikipedia'dan şirket genel bakışı
Jazz Pharmaceuticals plc is an American global biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003 in California, United States and is now headquartered in Dublin, Ireland.
Devamını oku
Jazz Pharmaceuticals plc (a merger of Jazz Pharmaceuticals, Inc. and Azur Pharma plc) is an American global biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003 in California, United States and is now headquartered in Dublin, Ireland.
One of the company's considerable products is the United States Food and Drug Administration (FDA) approved drug Xyrem (sodium oxybate), the sodium salt of the naturally occurring neurotransmitter γ-Hydroxybutyric acid (GHB). In 2017, net product sales of Xyrem were $1.187 billion, which represented 74% of the company's total net product sales. In 2019, Jazz was granted FDA-approval to market Sunosi with indications for treating excessive daytime sleepiness (EDS) in narcolepsy as well as obstructive sleep apnea (OSA). In 2022, it was announced that Axsome Therapeutics would be acquiring Sunosi from Jazz Pharmaceuticals.
In 2007, the company pled guilty to felony charges related to its illegal marketing of Xyrem for off-label use.
The company is also a member of the Pharmaceutical Research and Manufacturers of America (PhRMA).
Company history and acquisitions
2010–2019
On 18 February 2010, the FDA accepted a new drug application for JZP-6 (Sodium oxybate) for the treatment of Fibromyalgia. In the following December, a new patent was issued for Sodium Oxybate.
On September 19, 2011, Jazz Pharmaceuticals merged with Irish Azur Pharma plc to form Jazz Pharmaceuticals plc. The Azur Pharma seat in Dublin became the headquarters of the combined company. Azur Pharma had been marketing specialty pharmaceutical products in the central nervous system (CNS) and women's health areas with US operations in Philadelphia.
On 26 April 2012, the company acquired EUSA Pharma for $650 million (plus $50 million in milestone payments). In September, the company sold its Women's Health business to Meda for $95 million. In December, the company began clinical trial of intravenous Erwinaze in patients with Acute Lymphoblastic Leukemia.
In January 2014, the company announced it would acquire the rare disease drug developer Gentium SpA and its lead product Defitelio for $1 billion.
In May 2016, the company announced it would acquire Alizé Pharma II for $20.5 million. At the end of the same month, the company announced its then largest acquisition, with the purchase of Celator Pharmaceuticals for $1.5 billion. As a result, Jazz obtained the rights to breakthrough therapy Vyxeos (liposomal daunorubicin and cytarabine) for treatment of acute myeloid leukemia.
In August 2019, the company announced it would acquire Cavion Inc. for up to $310 million.
2020–present
In January 2021, Jazz announced it would acquire cannabis-focused medicinal drug company GW Pharmaceuticals for US$7.2 billion. This acquisition added the medication Epidiolex (cannabidiol), developed to treat severe epilepsy syndromes, to the company's portfolio.
In November 2025, Jazz Pharmaceuticals announced positive results from its Phase 3 trial for its cancer drug, Ziihera, a potential treatment for advanced gastroesophageal cancer.
Acquisition history
The following is an illustration of the company's mergers, acquisitions, spin-offs and historical predecessors:
== References ==
Kaynak: Wikipedia (İngilizce), CC BY-SA 4.0 · Wikipedia'da Görüntüle ↗
JAZZ Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$254.94
Piyasa Değeri
—
P/E (TTM)
-29.1
EPS (TTM)
$-5.84
Gelir (TTM)
$4.27B
Temettü Verimi
—
ROE
—
D/E Borç/Özsermaye
—
52 Haftlık Aralık
$118 – $265
JAZZ Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
Configure
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir ve Net Gelir
$4.27B
2016-12-31
→
2025-12-31
Hisse Başına Kâr
$-5.84
2016-12-31
→
2025-12-31
Serbest Nakit Akışı
—
Marjlar
—
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
Metrik
5 Yıllık trend
JAZZ
Akran Ortalaması
P/E (TTM)
-29.1
530.6
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
Metrik
5 Yıllık trend
JAZZ
Akran Ortalaması
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
Metrik
5 Yıllık trend
JAZZ
Akran Ortalaması
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
Metrik
5 Yıllık trend
JAZZ
Akran Ortalaması
Revenue YoY (Gelir Yıllık Bazda)
4.9%
—
Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı)
5.3%
—
Revenue CAGR 5Y (Gelir 5 Yıllık Bileşik Büyüme Oranı)
12.5%
—
EPS YoY (EPS YB)
41.8%
—
Net Income YoY (Net Gelir Yıllık Bazda)
35.0%
—
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
Metrik
5 Yıllık trend
JAZZ
Akran Ortalaması
JAZZ Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
AL
26 analist
- Güçlü Al 7 26,9%
- Al 17 65,4%
- Tut 2 7,7%
- Sat 0 0,0%
- Güçlü Sat 0 0,0%
12 Aylık Fiyat Hedefi
20 analist · 2026-08-15
Medyan
$285.00
Şimdi
$254.94
Düşük
$196.00
Yüksek
$315.00
Medyan hedef
$285.00
+11,8%
Ortalama hedef
$281.10
+10,3%
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
-0.06%
| Dönem | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|
| 30 Haziran 2026 | $5.71 | $6.30 | -0.59% |
| 31 Mart 2026 | $6.34 | $4.66 | 1.7% |
| 31 Aralık 2025 | $6.64 | $6.65 | -0.01% |
| 30 Eylül 2025 | $8.13 | $6.04 | 2.1% |
| 30 Haziran 2025 | $-8.25 | $-7.76 | -0.49% |
| 31 Mart 2025 | $1.68 | $4.75 | -3.1% |
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| JAZZ | — | -29.1 | 4.9% | — | — | — |
| GHRS | — | — | — | — | — | — |
| PRGO | $1.92B | -1.4 | -2.8% | -33.5% | -38.5% | 35.1% |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu 14
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.27B | $4.07B | $3.83B | $3.66B | $3.09B | $2.36B | $2.16B | $1.89B | $1.62B | $1.49B | $1.32B | $1.17B | |
| R&D Expense | · | · | · | · | · | · | $300M | $227M | $198M | $162M | $135M | $85M | |
| SG&A Expense | $1.81B | $1.39B | $1.34B | $1.42B | $1.45B | $854M | $737M | $684M | $544M | $503M | $449M | $406M | |
| Operating Expenses | $4.70B | $3.35B | $3.26B | $3.72B | $2.92B | $1.99B | $1.63B | $1.28B | $1.09B | $896M | $817M | $977M | |
| Operating Income | $-430M | $717M | $579M | $-66M | $170M | $378M | $532M | $615M | $529M | $592M | $508M | $196M | |
| Interest Income | $86M | $106M | $65M | $12M | $2M | $11M | $20M | $17M | $4M | · | · | · | |
| Other Non-op | · | · | · | · | · | · | · | · | · | · | $1M | $9M | |
| Pretax Income | $-628M | $470M | $298M | $-373M | $-113M | $275M | $454M | $529M | $441M | $532M | $436M | $152M | |
| Income Tax | $-272M | $-91M | $-120M | $-159M | $216M | $34M | $-73M | $80M | $-48M | $135M | $106M | $94M | |
| Net Income | $-356M | $560M | $415M | $-224M | $-330M | $239M | $523M | $447M | $488M | $397M | $330M | $58M | |
| EPS (Basic) | $-5.84 | $9.06 | $6.55 | $-3.58 | $-5.52 | $4.28 | $9.22 | $7.45 | $8.13 | $6.56 | $5.38 | $0.98 | |
| EPS (Diluted) | $-5.84 | $8.65 | $6.10 | $-3.58 | $-5.52 | $4.22 | $9.09 | $7.30 | $7.96 | $6.41 | $5.23 | $0.93 | |
| Shares (Basic) | 60,981,000 | 61,838,000 | 63,291,000 | 62,539,000 | 59,694,000 | 55,712,000 | 56,749,000 | 59,976,000 | 60,018,000 | 60,500,000 | 61,232,000 | 59,746,000 | |
| Shares (Diluted) | 60,981,000 | 66,007,000 | 72,066,000 | 62,539,000 | 59,694,000 | 56,517,000 | 57,550,000 | 61,221,000 | 61,317,000 | 61,870,000 | 63,036,000 | 62,614,000 |
Bilanço 26
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.39B | $2.41B | $1.51B | $881M | $591M | $1.06B | $637M | $310M | $386M | $366M | $989M | $684M | |
| Receivables | $831M | $717M | $706M | $651M | $563M | $396M | $356M | $264M | $224M | $234M | $210M | $186M | |
| Inventory | $417M | $480M | $597M | $714M | $1.07B | $95M | $79M | $53M | $43M | $34M | $19M | $30M | |
| Prepaid Expense | $152M | $177M | $185M | $92M | $131M | $62M | $39M | $25M | $23M | $25M | $21M | $13M | |
| Other Current Assets | $324M | $262M | $321M | $267M | $252M | $152M | $79M | $68M | $77M | $29M | $19M | $21M | |
| Current Assets | $4.17B | $4.63B | $3.44B | $2.61B | $2.61B | $2.84B | $1.63B | $1.23B | $968M | $748M | $1.26B | $1.02B | |
| PP&E (Net) | · | · | · | · | · | $128M | $132M | $200M | $170M | $107M | $86M | $58M | |
| PP&E (Gross) | · | · | · | · | · | $196M | $187M | $250M | $211M | $140M | $109M | $74M | |
| Accum. Depreciation | · | · | · | · | · | $68M | $55M | $50M | $41M | $32M | $24M | $15M | |
| Goodwill | $1.83B | $1.72B | $1.75B | $1.69B | $1.83B | $958M | $920M | $928M | $948M | $894M | $657M | $703M | |
| Intangibles | $4.43B | $4.76B | $5.42B | $5.79B | $7.15B | $2.20B | $2.44B | $2.73B | $2.98B | $3.01B | $1.19B | $1.44B | |
| Other Non-current Assets | $99M | $114M | $67M | $55M | $41M | $26M | $48M | $43M | $16M | $14M | $9M | $16M | |
| Total Assets | $11.66B | $12.01B | $11.39B | $10.84B | $12.30B | $6.54B | $5.54B | $5.20B | $5.12B | $4.80B | $3.33B | $3.34B | |
| Accounts Payable | $122M | $78M | $103M | $91M | $100M | $27M | $46M | $41M | $24M | $22M | $22M | $25M | |
| Accrued Liabilities | $1.03B | $911M | $794M | $803M | $666M | $353M | $270M | $265M | $199M | $193M | $164M | $164M | |
| Current Liabilities | $2.24B | $1.04B | $1.54B | $933M | $809M | $654M | $364M | $345M | $294M | $257M | $227M | $217M | |
| Capital Leases | $51M | $39M | $59M | $72M | $87M | $140M | $151M | $0 | · | · | · | · | |
| Deferred Tax | $594M | $677M | $848M | $944M | $1.30B | $130M | $224M | $309M | $383M | $557M | $283M | $375M | |
| Other Non-current Liabilities | $124M | $87M | $105M | $107M | $117M | $101M | $109M | $219M | $177M | $113M | $69M | $38M | |
| Long-term Debt | $5.36B | $6.11B | $5.71B | $5.72B | $6.05B | $2.09B | $1.61B | $1.60B | $1.58B | $2.03B | $1.19B | $1.34B | |
| Common Stock | $0 | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | |
| Retained Earnings | $646M | $1.13B | $879M | $734M | $830M | $1.16B | $1.07B | $841M | $918M | $529M | $303M | $35M | |
| AOCI | $-569M | $-948M | $-842M | $-1.13B | $-400M | $-134M | $-223M | $-198M | $-141M | $-317M | $-267M | $-122M | |
| Stockholders' Equity | $4.32B | $4.09B | $3.74B | $3.09B | $3.97B | $3.66B | $3.11B | $2.76B | $2.71B | $1.88B | $1.71B | $1.37B | |
| Liabilities + Equity | $11.66B | $12.01B | $11.39B | $10.84B | $12.30B | $6.54B | $5.54B | $5.20B | $5.12B | $4.80B | $3.33B | $3.34B | |
| Shares Outstanding | 61,400,000 | 60,600,000 | 62,255,000 | 63,214,000 | 61,633,000 | 56,171,000 | 56,140,000 | 57,704,000 | 58,898,000 | 59,820,000 | 61,305,000 | 60,643,000 |
Nakit Akışı 12
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $42M | $33M | $30M | $30M | $27M | $19M | $15M | $15M | $13M | $12M | $10M | · | |
| Stock-based Comp | $291M | $248M | $227M | $222M | $189M | $121M | $111M | $102M | $107M | $99M | $92M | $70M | |
| Deferred Tax | $-445M | $-208M | $-260M | $-292M | $69M | $-137M | $-237M | $-89M | $-226M | $-41M | $-68M | $-49M | |
| Amort. of Intangibles | $655M | $627M | $608M | $599M | $526M | $260M | $355M | $201M | $152M | $102M | $98M | $127M | |
| Restructuring | · | · | · | · | · | · | · | · | · | · | $2M | $2M | |
| Operating Cash Flow | $1.36B | $1.40B | $1.09B | $1.27B | $779M | $900M | $776M | $799M | $693M | $592M | $532M | $408M | |
| CapEx | $59M | $38M | $24M | $29M | $28M | $15M | $40M | $20M | $29M | $10M | $36M | $36M | |
| Investing Cash Flow | $-1.51B | $-508M | $-163M | $-446M | $-5.21B | $-1.01B | $-155M | $-394M | $-269M | $-1.75B | $-2M | $-1.07B | |
| Stock Repurchased | $125M | $311M | $270M | $54.0K | $0 | $147M | $301M | $524M | $99M | $278M | $62M | $42M | |
| Financing Cash Flow | $-873M | $21M | $-305M | $-529M | $3.97B | $528M | $-294M | $-479M | $-409M | $541M | $-214M | $711M | |
| Net Change in Cash | $-1.02B | $907M | $625M | $290M | $-466M | $420M | $328M | $-76M | $20M | $-623M | $305M | $48M | |
| Taxes Paid | $122M | $115M | $178M | · | · | · | · | · | · | · | · | · |
Büyüme Oranları 7
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 4.9% | 6.1% | 4.8% | 18.3% | 30.9% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 5.3% | 9.6% | 17.5% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 12.5% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | · | 41.8% | · | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | · | · | 13.1% | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | · | 35.0% | · | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | · | · | 20.2% | · | · | · | · | · | · | · | · | · |
Değerleme (TTM) 5
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4.27B | $4.07B | $3.83B | $3.66B | $3.09B | $2.36B | $2.16B | $1.89B | $1.62B | $1.49B | $1.32B | $1.17B | |
| Net Income TTM | $-356M | $560M | $415M | $-224M | $-330M | $239M | $523M | $447M | $488M | $397M | $330M | $58M | |
| P/E | -29.1 | 14.2 | 20.2 | -44.5 | -23.1 | 39.1 | 16.4 | 17.0 | 16.9 | 17.0 | 26.9 | 176.1 | |
| P / Tangible Book | · | · | · | · | · | 18.3 | · | · | · | · | · | · | |
| Earnings Yield | -3.4% | 7.0% | 5.0% | -2.2% | -4.3% | 2.6% | 6.1% | 5.9% | 5.9% | 5.9% | 3.7% | 0.57% |
Gelir Tablosu 13
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.21B | $1.07B | $1.20B | $1.13B | $1.05B | $898M | $1.09B | $1.05B | $1.02B | $902M | $1.01B | $972M | $957M | $893M | $972M | $941M | |
| SG&A Expense | $389M | $353M | $406M | $531M | $358M | $514M | $369M | $326M | $339M | $352M | $396M | $308M | $341M | $298M | $383M | $358M | |
| Operating Expenses | $960M | $732M | $943M | $1.07B | $1.73B | $954M | $897M | $795M | $824M | $836M | $889M | $800M | $800M | $767M | $1.24B | $916M | |
| Operating Income | $248M | $337M | $255M | $58M | $-686M | $-56M | $191M | $260M | $199M | $66M | $122M | $172M | $158M | $126M | $-263M | $25M | |
| Interest Income | $25M | $23M | $20M | $19M | $19M | $28M | $32M | $26M | $25M | $23M | $21M | $19M | $15M | $11M | $7M | $4M | |
| Pretax Income | $211M | $299M | $208M | $9M | $-736M | $-110M | $133M | $201M | $138M | $-2M | $62M | $100M | $82M | $55M | $-340M | $-60M | |
| Income Tax | $18M | $6M | $5M | $-242M | $-17M | $-18M | $-58M | $-15M | $-31M | $12M | $-33M | $-47M | $-24M | $-15M | $-100M | $-43M | |
| Net Income | $193M | $293M | $203M | $251M | $-718M | $-92M | $191M | $215M | $169M | $-15M | $94M | $147M | $104M | $69M | $-241M | $-20M | |
| EPS (Basic) | $3.05 | $4.73 | $3.28 | $4.14 | $-11.74 | $-1.52 | $3.11 | $3.50 | $2.68 | $-0.23 | $1.50 | $2.33 | $1.63 | $1.09 | $-3.86 | $-0.31 | |
| EPS (Diluted) | $2.78 | $4.43 | $3.34 | $4.08 | $-11.74 | $-1.52 | $2.97 | $3.42 | $2.49 | $-0.23 | $1.40 | $2.14 | $1.52 | $1.04 | $-3.85 | $-0.31 | |
| Shares (Basic) | 63,200,000 | 61,900,000 | -121,888,000 | 60,696,000 | 61,200,000 | 61,000,000 | -124,995,000 | 61,414,000 | 62,882,000 | 62,537,000 | -127,308,000 | 63,114,000 | 63,991,000 | 63,494,000 | -124,547,000 | 62,785,000 | |
| Shares (Diluted) | 69,400,000 | 66,100,000 | -122,798,000 | 61,606,000 | 61,200,000 | 61,000,000 | -129,329,000 | 63,174,000 | 69,625,000 | 62,537,000 | -146,538,000 | 71,293,000 | 73,540,000 | 73,771,000 | -126,584,000 | 62,785,000 | |
| EBITDA | $248M | $337M | · | $58M | $-686M | $-56M | · | $260M | $199M | $66M | · | $172M | $158M | $126M | · | $25M |
Bilanço 24
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.62B | $1.84B | $1.39B | $1.33B | $1.19B | $1.86B | $2.41B | $2.22B | $1.36B | $1.44B | · | $1.34B | $1.28B | $1.17B | · | $839M | |
| Receivables | $881M | $836M | $831M | $764M | $714M | $653M | $717M | $724M | $698M | $707M | · | $628M | $610M | $624M | · | $601M | |
| Inventory | $443M | $438M | $417M | $483M | $505M | $493M | $480M | $539M | $543M | $577M | · | $612M | $657M | $675M | · | $728M | |
| Prepaid Expense | $200M | $150M | $152M | $147M | $164M | $150M | $177M | $155M | $134M | $123M | · | $110M | $107M | $73M | · | $93M | |
| Other Current Assets | $244M | $285M | $324M | $315M | $298M | $260M | $262M | $354M | $326M | $315M | · | $310M | $272M | $245M | · | $250M | |
| Current Assets | $3.97B | $4.58B | $4.17B | $3.76B | $3.35B | $4.13B | $4.63B | $4.39B | $3.68B | $3.54B | · | $3.25B | $3.01B | $2.78B | · | $2.57B | |
| Goodwill | $1.80B | $1.80B | $1.83B | $1.83B | $1.84B | $1.76B | $1.72B | $1.80B | $1.74B | $1.74B | · | $1.71B | $1.74B | $1.72B | · | $1.59B | |
| Intangibles | $4.03B | $4.20B | $4.43B | $4.57B | $4.77B | $4.72B | $4.76B | $5.14B | $5.08B | $5.24B | · | $5.42B | $5.71B | $5.76B | · | $5.57B | |
| Other Non-current Assets | $86M | $95M | $99M | $103M | $121M | $117M | $114M | $75M | $71M | $71M | · | $76M | $66M | $64M | · | $35M | |
| Total Assets | $11.08B | $11.86B | $11.66B | $11.36B | $10.94B | $11.53B | $12.01B | $12.26B | $11.36B | $11.33B | · | $11.20B | $11.26B | $11.05B | · | $10.38B | |
| Accounts Payable | $128M | $100M | $122M | $152M | $89M | $96M | $78M | $85M | $97M | $81M | · | $110M | $98M | $125M | · | $102M | |
| Accrued Liabilities | $1.03B | $1.02B | $1.03B | $1.00B | $875M | $1.06B | $911M | $859M | $801M | $827M | · | $770M | $748M | $712M | · | $668M | |
| Current Liabilities | $2.23B | $2.25B | $2.24B | $2.27B | $2.07B | $1.22B | $1.04B | $1.03B | $1.56B | $1.56B | · | $1.57B | $945M | $909M | · | $813M | |
| Capital Leases | $44M | $47M | $51M | $53M | $55M | $39M | $39M | $71M | $68M | $56M | · | $62M | $66M | $72M | · | $73M | |
| Deferred Tax | $529M | $548M | $594M | $629M | $682M | $671M | $677M | $792M | $775M | $810M | · | $841M | $911M | $932M | · | $934M | |
| Other Non-current Liabilities | $141M | $162M | $125M | $109M | $94M | $91M | $87M | $111M | $99M | $97M | · | $127M | $127M | $109M | · | $124M | |
| Long-term Debt | $4.35B | $5.35B | $5.36B | $5.36B | $5.36B | $5.37B | $6.11B | $6.11B | $5.71B | $5.71B | · | $5.72B | $5.72B | $5.72B | · | $5.73B | |
| Total Debt | $4.35B | $5.35B | · | $5.36B | $5.36B | $5.37B | · | $6.11B | $5.71B | $5.71B | · | $5.72B | $5.72B | $5.72B | · | $5.73B | |
| Common Stock | $0 | $0 | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | · | $6.0K | $6.0K | $6.0K | · | $6.0K | |
| Retained Earnings | $1.13B | $939M | $646M | $443M | $191M | $1.03B | $1.13B | $936M | $871M | $864M | · | $884M | $812M | $803M | · | $974M | |
| AOCI | $-662M | $-651M | $-569M | $-570M | $-486M | $-786M | $-948M | $-603M | $-888M | $-882M | · | $-1.04B | $-867M | $-980M | · | $-1.62B | |
| Stockholders' Equity | $4.80B | $4.53B | $4.32B | $3.96B | $3.71B | $4.17B | $4.09B | $4.17B | $3.76B | $3.70B | $3.74B | $3.49B | $3.53B | $3.34B | $3.09B | $2.75B | |
| Liabilities + Equity | $11.08B | $11.86B | $11.66B | $11.36B | $10.94B | $11.53B | $12.01B | $12.26B | $11.36B | $11.33B | · | $11.20B | $11.26B | $11.05B | · | $10.38B | |
| Shares Outstanding | 64,800,000 | 62,700,000 | 61,435,000 | 60,740,000 | 60,640,000 | 61,623,000 | 60,631,000 | 60,443,000 | 61,745,000 | 63,028,000 | 62,255,000 | 62,945,000 | · | · | 63,214,000 | · |
Nakit Akışı 10
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $73M | $74M | $71M | $88M | $65M | $68M | $70M | $60M | $57M | $61M | $53M | $56M | $61M | $56M | $62M | $57M | |
| Deferred Tax | $-39M | $-66M | $-63M | $-271M | $-66M | $-44M | $-2M | $-64M | $-75M | $-66M | $-36M | $-79M | $-79M | $-66M | $-145M | $-65M | |
| Amort. of Intangibles | $170M | $172M | $170M | $168M | $162M | $154M | $159M | $157M | $155M | $156M | $152M | $155M | $152M | $150M | $137M | $141M | |
| Operating Cash Flow | $416M | $408M | $363M | $475M | $89M | $430M | $399M | $399M | $331M | $267M | $167M | $307M | $297M | $321M | $342M | $418M | |
| CapEx | $18M | $20M | $17M | $15M | $13M | $14M | $13M | $11M | $7M | $7M | $10M | $4M | $6M | $4M | $9M | $-5M | |
| Investing Cash Flow | $355M | $123M | $-372M | $-328M | $-641M | $-169M | $-193M | $214M | $-257M | $-272M | $102M | $-174M | $-86M | $-5M | $-324M | $5M | |
| Stock Repurchased | · | · | $0 | $0 | · | · | $0 | $150M | · | · | $100M | $74M | · | · | $0 | $0 | |
| Financing Cash Flow | $-994M | $-78M | $75M | $-11M | $-125M | $-814M | $-8M | $246M | $-161M | $-57M | $-100M | $-78M | $-97M | $-30M | $20M | $-289M | |
| Net Change in Cash | $-224M | $452M | $66M | $136M | $-672M | $-551M | $195M | $862M | $-88M | $-63M | $171M | $53M | $114M | $286M | $42M | $128M | |
| Free Cash Flow | · | $388M | · | · | · | $416M | · | · | · | $260M | · | · | · | $317M | · | · |
Kârlılık 7
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 20.5% | 31.5% | · | 5.1% | -65.6% | -6.2% | · | 24.7% | 19.5% | 7.3% | · | 17.7% | 16.5% | 14.1% | · | 2.6% | |
| Net Margin | 16.0% | 27.4% | · | 22.3% | -68.7% | -10.3% | · | 20.4% | 16.5% | -1.6% | · | 15.1% | 10.9% | 7.8% | · | -2.1% | |
| Pretax Margin | 17.5% | 28.0% | · | 0.80% | -70.3% | -12.2% | · | 19.0% | 13.5% | -0.18% | · | 10.2% | 8.5% | 6.2% | · | -6.4% | |
| EBITDA Margin | 20.5% | 31.5% | · | 5.1% | -65.6% | -6.2% | · | 24.7% | 19.5% | 7.3% | · | 17.7% | 16.5% | 14.1% | · | 2.6% | |
| ROA | 1.8% | 2.5% | · | 2.1% | -6.4% | -0.81% | · | 1.8% | 1.5% | -0.13% | · | 1.4% | 0.93% | 0.61% | · | -0.17% | |
| ROE | 4.5% | 6.7% | · | 6.2% | -19.2% | -2.4% | · | 5.6% | 4.6% | -0.42% | · | 4.7% | 3.1% | 2.0% | · | -0.59% | |
| ROIC | 2.5% | 3.3% | · | 17.2% | -7.4% | -0.49% | · | 2.7% | 2.6% | 5.8% | · | 2.8% | 2.2% | 1.8% | · | 0.08% |
Likidite ve Solventlik 4
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.8 | 2.0 | · | 1.7 | 1.6 | 3.4 | · | 4.3 | 2.4 | 2.3 | · | 2.1 | 3.2 | 3.1 | · | 3.2 | |
| Quick Ratio | 1.1 | 1.2 | · | 0.9 | 0.9 | 2.1 | · | 2.9 | 1.3 | 1.4 | · | 1.2 | 2.0 | 2.0 | · | 1.8 | |
| Debt / Equity | 0.9 | 1.2 | · | 1.4 | 1.4 | 1.3 | · | 1.5 | 1.5 | 1.5 | · | 1.6 | 1.6 | 1.7 | · | 2.1 | |
| LT Debt / Equity | 0.7 | 1.0 | · | 1.1 | 1.2 | 1.3 | · | 1.5 | 1.4 | 1.4 | · | 1.5 | 1.6 | 1.7 | · | 2.1 |
Verimlilik 2
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Receivables Turnover | 1.5 | 1.4 | · | 1.5 | 1.5 | 1.3 | · | 1.6 | 1.6 | 1.4 | · | 1.6 | 1.6 | 1.5 | · | 1.7 |
Değerleme (TTM) 13
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4.45B | $4.14B | · | $4.12B | $4.02B | $3.88B | · | $3.95B | $3.86B | $3.72B | · | $3.76B | $3.72B | $3.58B | · | $3.53B | |
| Net Income TTM | $19M | $-266M | · | $-345M | $-427M | $276M | · | $516M | $405M | $306M | · | $301M | $189M | $86M | · | $-36M | |
| Market Cap | $15.61B | $11.85B | · | $8.01B | $6.44B | $7.65B | · | $6.73B | $6.59B | $7.59B | · | $8.15B | · | · | · | · | |
| Enterprise Value | $18.35B | $15.36B | · | $12.04B | $10.61B | $11.16B | · | $10.63B | $10.94B | $11.86B | · | $12.53B | · | · | · | · | |
| P/E | -535.5 | -39.8 | · | -22.9 | -14.4 | 29.8 | · | 14.2 | 18.0 | 26.9 | · | 29.5 | 44.3 | 111.7 | · | -225.9 | |
| P/S | 3.5 | 2.9 | · | 1.9 | 1.6 | 2.0 | · | 1.7 | 1.7 | 2.0 | · | 2.2 | · | · | · | · | |
| P/B | 3.3 | 2.6 | · | 2.0 | 1.7 | 1.8 | · | 1.6 | 1.8 | 2.1 | · | 2.3 | · | · | · | · | |
| P / Cash Flow | · | 29.0 | · | · | · | 17.8 | · | · | · | 28.4 | · | · | · | · | · | · | |
| P / FCF | · | 30.5 | · | · | · | 18.4 | · | · | · | 29.2 | · | · | · | · | · | · | |
| EV / EBITDA | 73.9 | 45.6 | · | 209.4 | -15.5 | -199.6 | · | 40.8 | 54.9 | 179.1 | · | 72.7 | · | · | · | · | |
| EV / FCF | · | 39.5 | · | · | · | 26.8 | · | · | · | 45.5 | · | · | · | · | · | · | |
| EV / Revenue | 4.1 | 3.7 | · | 2.9 | 2.6 | 2.9 | · | 2.7 | 2.8 | 3.2 | · | 3.3 | · | · | · | · | |
| Earnings Yield | -0.19% | -2.5% | · | -4.4% | -6.9% | 3.4% | · | 7.0% | 5.5% | 3.7% | · | 3.4% | 2.3% | 0.90% | · | -0.44% |
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
Gelir Tablosu
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Gelir | $4.27B | $4.07B | $3.83B | $3.66B | $3.09B |
| Net Gelir | $-356M | $560M | $415M | $-224M | $-330M |
| Seyreltilmiş Hisse Başı Kâr | $-5.84 | $8.65 | $6.10 | $-3.58 | $-5.52 |
Son Haberler Bu şirketten bahseden son manşetler
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
📊
Sizin için önemli olan metrikleri seçin — yukarıdaki Tam Temeller'deki herhangi bir satırın yanındaki ➕ düğmesine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kurumsal Sahipler (13F) 692 dosya · $9.8B toplam · Tarih itibarıyla 30 Haziran 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 145 (+42 önceki Ç'ye göre) | 56 (-21 önceki Ç'ye göre) | 220 (+19 önceki Ç'ye göre) | 190 (+12 önceki Ç'ye göre) | -1.9M |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| FMR LLC | $846.470.147 | 3.512.762 | 8,60% | Hisse senetleri |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $731.636.247 | 3.036.213 | 7,43% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $657.763.761 | 2.729.650 | 6,68% | Hisse senetleri |
| Capital World Investors | $650.043.082 | 2.697.610 | 6,60% | Hisse senetleri |
| STATE STREET CORP | $481.895.662 | 1.999.816 | 4,89% | Hisse senetleri |
| FULLER & THALER ASSET MANAGEMENT, INC. | $394.839.917 | 1.638.544 | 4,01% | Hisse senetleri |
| DIMENSIONAL FUND ADVISORS LP | $390.196.222 | 1.619.274 | 3,96% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $297.928.728 | 1.236.065 | 3,03% | Hisse senetleri |
| AMERIPRISE FINANCIAL INC | $260.580.996 | 1.081.421 | 2,65% | Hisse senetleri |
| CITADEL ADVISORS LLC | $242.578.716 | 1.006.676 | 2,46% | Hisse senetleri |
| Swedbank AB | $233.208.837 | 967.792 | 2,37% | Hisse senetleri |
| MILLENNIUM MANAGEMENT LLC | $184.072.164 | 763.880 | 1,87% | Hisse senetleri |
| VICTORY CAPITAL MANAGEMENT INC | $165.478.678 | 686.719 | 1,68% | Hisse senetleri |
| NORGES BANK | $158.279.458 | 656.843 | 1,61% | Hisse senetleri |
| RENAISSANCE TECHNOLOGIES LLC | $135.442.731 | 562.073 | 1,38% | Hisse senetleri |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $129.891.746 | 539.037 | 1,32% | Hisse senetleri |
| Allianz Asset Management GmbH | $122.925.785 | 510.129 | 1,25% | Hisse senetleri |
| GMT Capital Corp | $109.279.895 | 453.500 | 1,11% | Hisse senetleri |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | $105.278.106 | 436.893 | 1,07% | Hisse senetleri |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $103.893.734 | 431.148 | 1,06% | Hisse senetleri |
| TWO SIGMA INVESTMENTS, LP | $96.439.086 | 400.212 | 0,98% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $95.008.929 | 394.277 | 0,96% | Hisse senetleri |
| SYSTEMATIC FINANCIAL MANAGEMENT LP | $89.279.867 | 370.502 | 0,91% | Hisse senetleri |
| Sofinnova Investments, Inc. | $88.036.221 | 365.341 | 0,89% | Hisse senetleri |
| Polaris Capital Management, LLC | $79.270.937 | 328.966 | 0,81% | Hisse senetleri |
| AMERICAN CENTURY COMPANIES INC | $77.695.234 | 322.427 | 0,79% | Hisse senetleri |
| Bank of New York Mellon Corp | $76.961.481 | 319.382 | 0,78% | Hisse senetleri |
| GOLDENTREE ASSET MANAGEMENT LP | $70.838.675 | 294.435 | 0,72% | Hisse senetleri |
| Qube Research & Technologies Ltd | $70.056.003 | 290.725 | 0,71% | Hisse senetleri |
| FRONTIER CAPITAL MANAGEMENT CO LLC | $66.815.854 | 277.279 | 0,68% | Hisse senetleri |
| Quantinno Capital Management LP | $65.906.960 | 273.506 | 0,67% | Hisse senetleri |
| Boston Trust Walden Corp | $64.110.068 | 266.050 | 0,65% | Hisse senetleri |
| BANK OF AMERICA CORP /DE/ | $60.589.497 | 251.440 | 0,62% | Hisse senetleri |
| Tri Locum Partners LP | $53.427.868 | 221.720 | 0,54% | Hisse senetleri |
| Iron Triangle Partners LP | $49.668.900 | 292.170 | 0,50% | Hisse senetleri |
| ARGENT CAPITAL MANAGEMENT LLC | $48.211.350 | 200.072 | 0,49% | Hisse senetleri |
| GOLDMAN SACHS GROUP INC | $45.527.185 | 188.933 | 0,46% | Hisse senetleri |
| PERCEPTIVE ADVISORS LLC | $40.964.900 | 170.000 | 0,42% | Hisse senetleri |
| RAYMOND JAMES FINANCIAL INC | $39.434.259 | 163.648 | 0,40% | Hisse senetleri |
| RHUMBLINE ADVISERS | $39.282.382 | 163.018 | 0,40% | Hisse senetleri |
| Holocene Advisors, LP | $38.794.001 | 160.991 | 0,39% | Hisse senetleri |
| Saturn V Capital Management LP | $38.781.230 | 160.938 | 0,39% | Hisse senetleri |
| PFM Health Sciences, LP | $38.740.265 | 160.768 | 0,39% | Hisse senetleri |
| Retirement Systems of Alabama | $38.473.993 | 159.663 | 0,39% | Hisse senetleri |
| Woodline Partners LP | $36.165.501 | 150.083 | 0,37% | Hisse senetleri |
| LOOMIS SAYLES & CO L P | $35.355.338 | 146.721 | 0,36% | Hisse senetleri |
| Pictet Asset Management Holding SA | $35.115.175 | 147.599 | 0,36% | Hisse senetleri |
| PRINCIPAL FINANCIAL GROUP INC | $34.163.762 | 141.776 | 0,35% | Hisse senetleri |
| STIFEL FINANCIAL CORP | $33.583.066 | 139.365 | 0,34% | Hisse senetleri |
| BNP PARIBAS FINANCIAL MARKETS | $33.026.625 | 137.057 | 0,34% | Hisse senetleri |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $32.383.478 | 134.388 | 0,33% | Hisse senetleri |
| California Public Employees Retirement System | $30.759.098 | 127.647 | 0,31% | Hisse senetleri |
| WEDGE CAPITAL MANAGEMENT L L P/NC | $30.249.134 | 160.006 | 0,31% | Hisse senetleri |
| Robeco Institutional Asset Management B.V. | $28.340.967 | 117.612 | 0,29% | Hisse senetleri |
| Gotham Asset Management, LLC | $26.992.014 | 112.014 | 0,27% | Hisse senetleri |
| Aristotle Capital Management, LLC | $26.915.626 | 111.697 | 0,27% | Hisse senetleri |
| Swiss National Bank | $26.771.767 | 111.100 | 0,27% | Hisse senetleri |
| STOREBRAND ASSET MANAGEMENT AS | $26.309.828 | 109.183 | 0,27% | Hisse senetleri |
| CANADA PENSION PLAN INVESTMENT BOARD | $25.928.372 | 107.600 | 0,26% | Hisse senetleri |
| PANAGORA ASSET MANAGEMENT INC | $25.286.187 | 104.935 | 0,26% | Hisse senetleri |
| BlackRock, Inc. | $23.889.284 | 99.138 | 0,24% | Hisse senetleri |
| Perpetual Ltd | $23.733.376 | 98.491 | 0,24% | Hisse senetleri |
| WELLINGTON MANAGEMENT GROUP LLP | $23.658.917 | 98.182 | 0,24% | Hisse senetleri |
| MORGAN STANLEY | $23.519.795 | 97.604 | 0,24% | Hisse senetleri |
| Man Group plc | $23.299.389 | 96.690 | 0,24% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $22.868.053 | 94.900 | 0,23% | Satım opsiyonu |
| ENVESTNET ASSET MANAGEMENT INC | $22.061.835 | 91.554 | 0,22% | Hisse senetleri |
| Rhenman & Partners Asset Management AB | $21.070.417 | 87.440 | 0,21% | Hisse senetleri |
| Aberdeen Group plc | $20.146.538 | 83.606 | 0,20% | Hisse senetleri |
| Amundi | $19.114.464 | 79.323 | 0,19% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $18.916.145 | 78.500 | 0,19% | Alım opsiyonu |
| Schonfeld Strategic Advisors LLC | $18.620.232 | 77.272 | 0,19% | Hisse senetleri |
| FIRST TRUST ADVISORS LP | $18.149.860 | 75.320 | 0,18% | Hisse senetleri |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $17.765.513 | 73.725 | 0,18% | Hisse senetleri |
| LAZARD ASSET MANAGEMENT LLC | $16.768.620 | 69.588 | 0,17% | Hisse senetleri |
| Longaeva Partners L.P. | $16.576.808 | 68.792 | 0,17% | Hisse senetleri |
| Simplify Asset Management Inc. | $16.520.903 | 68.560 | 0,17% | Hisse senetleri |
| ALLIANCEBERNSTEIN L.P. | $16.497.448 | 87.265 | 0,17% | Hisse senetleri |
| Distillate Capital Partners LLC | $16.167.159 | 67.092 | 0,16% | Hisse senetleri |
| SEB Asset Management AB | $15.890.255 | 65.943 | 0,16% | Hisse senetleri |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $15.380.484 | 64.700 | 0,16% | Hisse senetleri |
| SEI INVESTMENTS CO | $14.931.224 | 61.963 | 0,15% | Hisse senetleri |
| Illinois Municipal Retirement Fund | $14.911.947 | 61.883 | 0,15% | Hisse senetleri |
| Tweedy, Browne Co LLC | $14.494.105 | 60.149 | 0,15% | Hisse senetleri |
| MARTINGALE ASSET MANAGEMENT L P | $14.335.788 | 59.492 | 0,15% | Hisse senetleri |
| DeepCurrents Investment Group LLC | $14.132.168 | 58.647 | 0,14% | Hisse senetleri |
| WORLDQUANT MILLENNIUM ADVISORS LLC | $13.348.774 | 55.396 | 0,14% | Hisse senetleri |
| VANGUARD ASSET MANAGEMENT, Ltd | $12.952.138 | 53.750 | 0,13% | Hisse senetleri |
| ExodusPoint Capital Management, LP | $12.819.845 | 53.201 | 0,13% | Hisse senetleri |
| Squarepoint Ops LLC | $12.807.074 | 53.148 | 0,13% | Hisse senetleri |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $12.034.356 | 63.657 | 0,12% | Hisse senetleri |
| ALGERT GLOBAL LLC | $11.749.697 | 48.760 | 0,12% | Hisse senetleri |
| CASTLEARK MANAGEMENT LLC | $11.306.312 | 46.920 | 0,11% | Hisse senetleri |
| CITADEL ADVISORS LLC | $11.253.299 | 46.700 | 0,11% | Alım opsiyonu |
| RENAISSANCE GROUP LLC | $11.221.601 | 46.568 | 0,11% | Hisse senetleri |
| Nuveen, LLC | $11.184.623 | 46.415 | 0,11% | Hisse senetleri |
| PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO | $10.859.795 | 45.067 | 0,11% | Hisse senetleri |
| Foundry Partners, LLC | $10.730.160 | 86.429 | 0,11% | Hisse senetleri |
| Legal & General Group Plc | $10.402.916 | 43.171 | 0,11% | Hisse senetleri |
| DEAN INVESTMENT ASSOCIATES, LLC | $10.273.274 | 42.633 | 0,10% | Hisse senetleri |
Şirket yöneticileri 50 içeriden öğrenenler · 4 yöneticiler · 4 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Renee D Gala | President & CEO | 30 Haziran 2026 F | 147.361 | 0 | 0 | $0 |
| Philip L Johnson | EVP & Chief Financial Officer | 30 Haziran 2026 F | 56.431 | 0 | 0 | $0 |
| Neena M Patil | EVP & Chief Legal Officer | 30 Haziran 2026 F | 48.871 | 0 | 2 | $-560.664 |
| Robert Iannone | EVP, Global Head of R&D & CMO | 30 Haziran 2026 F | 85.107 | 0 | 0 | $0 |
| Bryan C Cressey | Yönetim kurulu üyesi | 09 Mart 2012 S | 27.631 | 0 | 0 | $0 |
| Zilkha M Nathaniel | Yönetim kurulu üyesi | 10 Mart 2011 A | — | 0 | 0 | $0 |
| Alexander E Albert | Yönetim kurulu üyesi | 15 Ağustos 2008 A | — | 0 | 0 | $0 |
| Patel Jaimin | Yönetim kurulu üyesi | 15 Ağustos 2007 A | — | 0 | 0 | $0 |
| Patrick Kennedy | — | 05 Ağustos 2026 A | 8.307 | 0 | 0 | $0 |
| Samantha Pearce | — | 05 Ağustos 2026 F | 47.131 | 0 | 1 | $-1.625.977 |
| Mark Douglas Smith | — | 05 Ağustos 2026 A | 11.285 | 0 | 1 | $-266.746 |
| Jennifer E. Cook | — | 05 Ağustos 2026 A | 12.442 | 0 | 0 | $0 |
| Laura Hamill | — | 05 Ağustos 2026 A | 8.538 | 0 | 0 | $0 |
| Heather Ann Mcsharry | — | 05 Ağustos 2026 A | 20.054 | 0 | 0 | $0 |
| Seamus Mulligan | — | 05 Ağustos 2026 A | 1.184.633 | 0 | 0 | $0 |
| Rick E Winningham | — | 05 Ağustos 2026 A | 11.172 | 0 | 2 | $-1.656.873 |
| Patrick G. Enright | — | 05 Ağustos 2026 A | 22.984 | 0 | 0 | $0 |
| Bruce C Cozadd | — | 05 Ağustos 2026 A | 362.287 | 0 | 20 | $-25.646.326 |
| Ted W Love | — | 05 Ağustos 2026 A | 3.132 | 0 | 0 | $0 |
| Norbert G Riedel | — | 05 Ağustos 2026 A | 8.629 | 0 | 1 | $-655.680 |
| Kenneth W O'Keefe | — | 02 Aralık 2025 F | 25.811 | 0 | 0 | $0 |
| Daniel N Swisher JR | — | 03 Ocak 2019 F | 16.512 | 0 | 0 | $0 |
| Suzanne Sawochka Hooper | — | 14 Aralık 2018 M | 41.184 | 0 | 0 | $0 |
| Matthew P. Young | — | 23 Kasım 2018 S | 32.068 | 0 | 0 | $0 |
| MILLER MICHAEL PATRICK | — | 13 Kasım 2018 S | 24.972 | 0 | 0 | $0 |
| Paul Treacy | — | 10 Ağustos 2018 S | 17.458 | 0 | 0 | $0 |
| Elmar Schnee | — | 09 Ağustos 2018 A | 6.094 | 0 | 0 | $0 |
| Peter Gray | — | 09 Ağustos 2018 A | 8.182 | 0 | 0 | $0 |
| Catherine A. Sohn | — | 09 Ağustos 2018 A | 7.654 | 0 | 0 | $0 |
| Paul L Berns | — | 09 Ağustos 2018 A | 6.772 | 0 | 0 | $0 |
| Karen J Wilson | — | 11 Mayıs 2018 S | 15.757 | 0 | 0 | $0 |
| Karen L. Smith | — | 05 Mart 2018 F | 28.474 | 0 | 0 | $0 |
| Iain Mcgill | — | 05 Mart 2018 F | 22.048 | 0 | 0 | $0 |
| Russell J. Cox | — | 06 Mart 2017 F | 52.795 | 0 | 0 | $0 |
| Jeffrey K Tobias | — | 05 Mart 2015 F | 38.484 | 0 | 0 | $0 |
| Fintan Keegan | — | 08 Temmuz 2014 M | 31.750 | 0 | 0 | $0 |
| Kathryn E Falberg | — | 05 Mart 2014 F | 133.387 | 0 | 0 | $0 |
| James C Momtazee | — | 13 Ağustos 2013 S | 17.315 | 0 | 0 | $0 |
| Carol A Gamble | — | 09 Mart 2012 S | 32.213 | 0 | 0 | $0 |
| Alan Sebulsky | — | 09 Mart 2012 S | 54.355 | 0 | 0 | $0 |
| Samuel D Colella | — | 11 Ocak 2012 M | 38.347 | 0 | 0 | $0 |
| Michael W Michelson | — | 11 Ocak 2012 M | 13.885 | 0 | 0 | $0 |
| Mark G. Eller | — | 13 Ağustos 2011 M | 4.151 | 0 | 0 | $0 |
| Michael A. Desjardin | — | 13 Ağustos 2011 M | 14.574 | 0 | 0 | $0 |
| Janne Lt Wissel | — | 31 Mayıs 2011 J | 48.544 | 0 | 0 | $0 |
| Joan Colligan | — | 30 Kasım 2010 J | 14.424 | 0 | 0 | $0 |
| Robert M Myers | — | 30 Kasım 2010 J | 156.898 | 0 | 0 | $0 |
| James B Tananbaum | — | 25 Ağustos 2010 A | 21.366 | 0 | 0 | $0 |
| Samuel R Saks | — | 21 Ocak 2009 A | 358.868 | 0 | 0 | $0 |
| Matthew K Fust | — | 28 Kasım 2008 J | 58.948 | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
Aktivistler ve %5+ sahipler 6 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| Jazz Pharmaceuticals Public Limited Company, Jazz Financing I Limited, Jazz Investments II Limited, Jazz Pharmaceuticals Italy S.p.A. ×4 başvurular | 20 Haziran 2014 | — | İlk başvuru | — | SEC |
| KKR JP LLC, KKR Millennium Fund L.P., KKR Associates Millennium L.P., KKR Millennium GP LLC, KKR Fund Holdings L.P., KKR Fund Holdings GP Limited, KKR Group Holdings L.P., KKR Group Limited, KKR & Co. L.P., KKR Management LLC, KKR JP III LLC, KKR Partners III, L.P., KKR III GP LLC, Henry R. Kravis, George R. Roberts ×3 başvurular | 12 Mart 2013 | — | İlk başvuru | — | SEC |
| Longitude Capital Partners, LLC, Longitude Venture Partners, L.P., Longitude Capital Associates, L.P., Patrick G. Enright, Juliet Tammenoms Bakker ×3 başvurular | 14 Mart 2012 | — | İlk başvuru | Sermaye yapısı | SEC |
| Longitude Capital Partners, LLC (2), Longitude Venture Partners, L.P. (2), Longitude Capital Associates, L.P. (2), Patrick G. Enright (2), Juliet Tammenoms Bakker (2) ×3 başvurular | 30 Eylül 2011 | — | İlk başvuru | — | SEC |
| Azur Pharma Limited | 28 Eylül 2011 | — | İlk başvuru | M&A / satış | SEC |
| Jazz Pharmaceuticals, Inc., KKR Millennium Fund L.P., KKR Associates Millennium L.P., KKR Millennium GP LLC, KKR Partners III, L.P., KKR III GP LLC, KKR JP LLC, KKR JP III LLC | 28 Nisan 2005 | — | İlk başvuru | M&A / satış | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF sahipliği 72 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
| Fon | Ağırlık | Birimler | Tarih itibarıyla | Kaynak |
|---|---|---|---|---|
| PILL · Direxion Shares ETF Trust | 1,47% | 931 NS | 30 Nisan 2026 | N-PORT |
| LSVD · ADVISORS' INNER CIRCLE FUND | 0,50% | 14.803 NS | 30 Nisan 2026 | N-PORT |
| AVMV · AMERICAN CENTURY ETF TRUST | 0,49% | 12.809 NS | 31 Mayıs 2026 | N-PORT |
| AVLV · AMERICAN CENTURY ETF TRUST | 0,28% | 154.718 NS | 31 Mayıs 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,25% | 169.973 NS | 30 Nisan 2026 | N-PORT |
| MIDU · Direxion Shares ETF Trust | 0,24% | 1.006 NS | 30 Nisan 2026 | N-PORT |
| NUSC · Nushares ETF Trust | 0,23% | 14.796 NS | 30 Nisan 2026 | N-PORT |
| AVMC · AMERICAN CENTURY ETF TRUST | 0,20% | 3.508 NS | 31 Mayıs 2026 | N-PORT |
| DFAT · Dimensional ETF Trust | 0,17% | 113.983 NS | 30 Nisan 2026 | N-PORT |
| DFSV · Dimensional ETF Trust | 0,16% | 59.597 NS | 30 Nisan 2026 | N-PORT |
| AVUQ · AMERICAN CENTURY ETF TRUST | 0,15% | 1.679 NS | 31 Mayıs 2026 | N-PORT |
| AVIE · AMERICAN CENTURY ETF TRUST | 0,14% | 59 NS | 31 Mayıs 2026 | N-PORT |
| AVSU · AMERICAN CENTURY ETF TRUST | 0,13% | 2.492 NS | 31 Mayıs 2026 | N-PORT |
| AVLC · AMERICAN CENTURY ETF TRUST | 0,08% | 4.239 NS | 31 Mayıs 2026 | N-PORT |
| AVUS · AMERICAN CENTURY ETF TRUST | 0,08% | 42.911 NS | 31 Mayıs 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,07% | 2.294 NS | 31 Mayıs 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,07% | 147.813 NS | 30 Nisan 2026 | N-PORT |
| DFUV · Dimensional ETF Trust | 0,06% | 45.962 NS | 30 Nisan 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,05% | 7.081 NS | 30 Nisan 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,02% | 13.414 NS | 30 Nisan 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,02% | 434 NS | 30 Nisan 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,02% | 17.653 NS | 30 Nisan 2026 | N-PORT |
| MSLC · MORGAN STANLEY PATHWAY FUNDS | 0,01% | 2.233 NS | 31 Mayıs 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | — | — | 15 Temmuz 2026 | Günlük |
| VB · VANGUARD INDEX FUNDS | — | — | 15 Temmuz 2026 | Günlük |
| VBR · VANGUARD INDEX FUNDS | — | — | 15 Temmuz 2026 | Günlük |
| VTI · VANGUARD INDEX FUNDS | — | — | 15 Temmuz 2026 | Günlük |
| VFMO · VANGUARD WELLINGTON FUND | — | — | 30 Temmuz 2026 | Günlük |
| VFVA · VANGUARD WELLINGTON FUND | — | — | 30 Temmuz 2026 | Günlük |
| VFMF · VANGUARD WELLINGTON FUND | — | — | 30 Temmuz 2026 | Günlük |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | — | — | 15 Temmuz 2026 | Günlük |
| IVOO · VANGUARD ADMIRAL FUNDS | — | — | 15 Temmuz 2026 | Günlük |
| IVOG · VANGUARD ADMIRAL FUNDS | — | — | 15 Temmuz 2026 | Günlük |
| VONE · VANGUARD SCOTTSDALE FUNDS | — | — | 15 Temmuz 2026 | Günlük |
| VONV · VANGUARD SCOTTSDALE FUNDS | — | — | 15 Temmuz 2026 | Günlük |
| VTHR · VANGUARD SCOTTSDALE FUNDS | — | — | 15 Temmuz 2026 | Günlük |
| IJH · iShares Trust | — | — | 18 Ağustos 2026 | Günlük |
| IJK · iShares Trust | — | — | 07 Ağustos 2026 | Günlük |
| ITOT · iShares Trust | — | — | 22 Temmuz 2026 | Günlük |
| IWS · iShares Trust | — | — | 18 Ağustos 2026 | Günlük |
| IWR · iShares Trust | — | — | 07 Ağustos 2026 | Günlük |
| IUSG · iShares Trust | — | — | 06 Ağustos 2026 | Günlük |
| IWV · iShares Trust | — | — | 18 Ağustos 2026 | Günlük |
| IWD · iShares Trust | — | — | 14 Ağustos 2026 | Günlük |
| IWB · iShares Trust | — | — | 18 Ağustos 2026 | Günlük |
| IHE · iShares Trust | — | — | 18 Ağustos 2026 | Günlük |
| SMMD · iShares Trust | — | — | 18 Ağustos 2026 | Günlük |
| XJH · iShares Trust | — | — | 06 Ağustos 2026 | Günlük |
| PJP · Invesco Exchange-Traded Fund Trust | — | — | 06 Ağustos 2026 | Günlük |
| PRF · Invesco Exchange-Traded Fund Trust | — | — | 06 Ağustos 2026 | Günlük |